Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 394Neoplasms 351Carcinoma, Non-Small-Cell Lung 303Prostatic Neoplasms 255Colorectal Neoplasms 226Lung Neoplasms 197Multiple Myeloma 162Ovarian Neoplasms 152Neoplasm Metastasis 146Pancreatic Neoplasms 142Leukemia, Myeloid, Acute 135Melanoma 117Squamous Cell Carcinoma of Head and Neck 98Recurrence 96Carcinoma, Renal Cell 94Lymphoma 92Endometrial Neoplasms 92Brain Neoplasms 92Lymphoma, Non-Hodgkin 91Stomach Neoplasms 88Carcinoma, Hepatocellular 87Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Head and Neck Neoplasms 80Glioblastoma 79Uterine Cervical Neoplasms 78Hematologic Neoplasms 76Urinary Bladder Neoplasms 74Leukemia, Lymphocytic, Chronic, B-Cell 74Glioma 74Triple Negative Breast Neoplasms 69

Interventions

liposomal doxorubicin 1Zidovudine 1Vincristine 1Valganciclovir 1Sirolimus 1Rituximab 1Prednisone 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Macular dystrophy, corneal type 1 × 30 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡